PROTEANNSEProtean eGov Technologies Limited· IT - ServicesHighNeutral
Announced Thu, 6 Nov, 2025 · 18:44 IST

Protean Q2 FY26: Revenue up 19% YoY, PAT flat at Rs 26 Cr

Negative Operating CashflowEbitda Margin CompressionResults View source PDFExplain this filing

PROTEAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.1%Reaction day
₹854.95
prior close
₹853.65
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-1.5% vs market
IT Enabled Services peers, median of 69sector+0.5%-1.5% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.5 pts less than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.0
10m
-2.1
15m
-2.2
30m
-1.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.1+0.4-1.5+0.5-1.5
Next day
-1.9+0.0-1.9-0.7-1.2
2d
-1.5-0.2-1.2-0.7-0.7
3d
+2.0+0.7+1.3-0.3+2.3
4d
-0.5+0.6-1.1-0.2-0.2
5d
-0.6+0.5-1.1-0.7+0.1
1w
-2.2+0.3-2.5-1.4-0.8
15d
-5.1-1.5-3.7-3.4-1.7
1m
-10.1-6.6-3.6-7.9-2.2
2m
-11.7-3.2-8.5-6.3-5.4
3m
-22.7-5.2-17.5-12.1-10.6
UpDownMarket · Nifty Microcap 250Sector · IT Enabled Services peers, median of 69Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Protean eGov reported Q2 FY26 standalone revenue of Rs 249.50 Cr, up 18.8% YoY from Rs 209.98 Cr. PAT was nearly flat at Rs 26.20 Cr vs Rs 26.50 Cr. H1 FY26 revenue grew 10.5% to Rs 459.48 Cr with PAT at Rs 52.70 Cr. System support costs surged, squeezing margins. Operating cashflow turned negative at minus Rs 47.71 Cr in H1 due to a sharp rise in receivables, vs positive Rs 74.93 Cr last year. Auditors gave an unqualified review report.

Likely market impact

Revenue growth is healthy but margin pressure and negative operating cashflow from rising receivables are key concerns for shareholders.